Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Berger

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neuropharmacological characterization of local ibogaine effects on dopamine releaseM S Reid, K Hsu, K H Souza, et al.
Pediatric Clinics of North America|July 8, 1998
Caring for the graduate from the neonatal intensive care unit. At home, in the office, and in the communityS P Berger, I Holt-Turner, J M Cupoli, et al.
Kidney International|December 15, 2000
Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitroS P Berger, M Hünger, B A Yard, et al.
Brain Research|May 2, 1998
Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatmentM S Reid, L B Ho, B K Tolliver, et al.
Drug and Alcohol Dependence|April 17, 1998
An acute dose of nicotine enhances cue-induced cocaine cravingM S Reid, J D Mickalian, K L Delucchi, et al.
The Netherlands Journal of Medicine|August 1, 2015
Immunosuppressive therapy in patients with IgA nephropathyH P E Peters, J A J van den Brand, S P Berger, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 6, 2017
[Waiting list registration for kidney transplants must improve]B J J M Haase-Kromwijk, M B A Heemskerk, W Weimar, et al.
Molecular Pharmacology|April 1, 1991
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935S P Berger, R E Martenson, P Laing, et al.
Lancet (London, England)|February 24, 1996
Haloperidol antagonism of cue-elicited cocaine cravingS P Berger, S Hall, J D Mickalian, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivoB K Tolliver, A H Newman, J L Katz, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Neuropharmacological characterization of local ibogaine effects on dopamine releaseM S Reid, K Hsu, K H Souza, et al.
Pediatric Clinics of North America|July 8, 1998
Caring for the graduate from the neonatal intensive care unit. At home, in the office, and in the communityS P Berger, I Holt-Turner, J M Cupoli, et al.
Kidney International|December 15, 2000
Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitroS P Berger, M Hünger, B A Yard, et al.
Brain Research|May 2, 1998
Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatmentM S Reid, L B Ho, B K Tolliver, et al.
Drug and Alcohol Dependence|April 17, 1998
An acute dose of nicotine enhances cue-induced cocaine cravingM S Reid, J D Mickalian, K L Delucchi, et al.
The Netherlands Journal of Medicine|August 1, 2015
Immunosuppressive therapy in patients with IgA nephropathyH P E Peters, J A J van den Brand, S P Berger, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 6, 2017
[Waiting list registration for kidney transplants must improve]B J J M Haase-Kromwijk, M B A Heemskerk, W Weimar, et al.
Molecular Pharmacology|April 1, 1991
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935S P Berger, R E Martenson, P Laing, et al.
Lancet (London, England)|February 24, 1996
Haloperidol antagonism of cue-elicited cocaine cravingS P Berger, S Hall, J D Mickalian, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivoB K Tolliver, A H Newman, J L Katz, et al.
Pageof 5